« Previous
Next »
Urology
Volume 74, Issue 5
, Pages 994-999
, November 2009
Celecoxib in the Management of Acute Renal Colic: A Randomized Controlled Clinical Trial
References
- . Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848–857
- Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol. 2007;177:983–987Discussion: 987
- . Statistical Power Analysis for the Behavioral Sciences. 2nd ed.. Hillsdale NJ: Lawrence Erlbaum Associates; 1988;
- . Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999;162:688–690
- . Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol. 1993;24:172–176
- . Effects of selective inhibitors of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) on the spontaneous myogenic contractions in the upper urinary tract of the guinea pig and rat. Br J Pharmacol. 2000;129:661–670
- Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic?. J Urol. 2000;163:607–612
- . Effects of prostaglandins and prostaglandin synthetase inhibitors on acutely obstructed kidneys in the dog. Urol Int. 1991;47:64–69
- . Increase in enzyme activities of prostaglandin biosynthesis and catabolism by acute ureteral ligation in rat kidney. Life Sci. 1985;37:1249–1255
- . The effect of indomethacin on the motility of isolated sheep ureters. Acta Pharmacol Toxicol. 1985;56:298–301
- Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits (Inflammatory response involving fibroblasts and mononuclear cells). J Clin Invest. 1983;71:81–90
- . Renal vascular resistance during elevated ureteral pressure. Circul Res. 1964;15(suppl 1):1–148
- . The effect of indomethacin on renal blood flow and ureteral pressure in unilateral obstruction in awake dogs. Invest Urol. 1978;15:324–328
- . Prostaglandins, a link between renal hydro- and hemodynamics in dogs. Acta Pharmacol Toxicol. 1976;97:369–376
- . The effect of indomethacin on glomerular capillary pressure and renal pelvic pressure in utereral obstruction. Scand J Urol Nephrol. 1982;75:31–34
- . The effect of indomethacin on renal function in pentobarbital-anesthetized dogs. J Pharmacol Exp Ther. 1976;198:457–463
- . Treatment of ureteral colic with intravenous indomethacin. J Urol. 1978;120:676–677
- The effect of indomethacin in ureteral motility. Br J Pharmacol. 1984;82:230
- . The action of the prostaglandins on isolated human ureteric smooth muscle. Br J Urol. 1988;61:19–26
- . Selective suppression of platlet thromboxane formation with sparing of vascular prostacyclin synthesis by aqueous extract of garlic in rabbits. Prostaglandins Leukot Med. 1986;25:139–146
- A double-blind single dose comparison of intramuscular ketorolac tromethamine and pethidine in the treatment of renal colic. J Clin Pharmacol. 1990;30:336–341
- Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology. 2000;56:579–582
- Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol. 1994;152:1095–1098
- . Intensive medical management of ureteral calculi. Urology. 2000;56:575–578
- Indomethacin suppositories versus intravenously titrated morphine for the treatment of ureteral colic. Ann Emerg Med. 1994;23:262–269
- Diclofenac sodium and spasmolytic drugs in the treatment of ureteral colic: a comparative study. Int Urol Nephrol. 1991;23:227–230
- . Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. J Pak Med Assoc. 1991;41:268–270
- Effects of spasmolytic and/or non-steroidal antiinflammatory drugs on muscle hyperalgesia of ureteral origin of rats. Eur J Pharmacol. 1995;278:97–101
- . Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104:413–421
- Intravenous morphine plus ketorolac is superior to either drug alone for treatment of acute renal colic. Ann Emerg Med. 2006;48:173–181
Funded by Pfizer Pharmaceuticals.
PII: S0090-4295(09)00614-1
doi: 10.1016/j.urology.2009.04.063
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Urology
Volume 74, Issue 5
, Pages 994-999
, November 2009
